Mark P. Lythgoe

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

Hamzah Abu‐Sbeih, David M. Faleck, Biagio Ricciuti et al. · Journal of Clinical Oncology · 2019 · 188 citations · Full text

Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos et al. · Cancer · 2019 · 89 citations · Full text

Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019

Mark P. Lythgoe, Aakash Desai, Bishal Gyawali et al. · JAMA Network Open · 2022 · 73 citations · Full text

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos et al. · European Urology Oncology · 2021 · 60 citations · Full text

Urology, Cancer Immunosurveillance, Genitourinary Cancer +7

Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study

Natalie Miller, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos et al. · The Journal of Urology · 2020 · 58 citations · Full text